Angiogenesis
AngioGenex/BioCheck Collaboration Produces Novel Antibodies, Revenue and Progress toward a Cancer Diagnostic
Published in Cancer Weekly, May 15th, 2007
AngioGenex, Inc. announced that under the leadership of Dr. John Chen, BioCheck Inc., is applying its resources and expertise to the development of a diagnostic for the early detection and prognosis of cancer based on the appearance of Id proteins in blood and tumor tissue. The sale of monoclonal antibodies to the Id proteins prepared by BioCheck has begun to generate revenue and AngioGenex will earn its first milestone payment of $50,000 at the end of the second quarter of 2007. This work is being conducted pursuant to a development and marketing agreement under which AngioGenex has assigned BioCheck exclusive rights to develop and market the cancer diagnostic in return for royalties,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-15)
More Articles from Cancer Weekly
- Monoclonal Antibodies
Magnesium loss in patients given monoclonal antibodies - Actavis
Sindan to rebrand as Actavis - Anemia
Researchers Urge Caution in Using ESAs for Cancer-Related Anemia - Bird Flu
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals - Bladder Cancer
Spectrum Pharmaceuticals Initiates Phase 3, Registrational Trials With EOquin in Non-Invasive Bladder Cancer - Brain Cancer
Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board Chaired by Company Co-founder, John L. Gainer, Ph.D. - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
